RankAlpha logo
Back to Rankings

BCRX

BioCrystA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
BCRX vs peer average
74/100
BCRX vs. peer average (A vs. B)
Grade spread
A 2 · B 3 · D 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PHVS is the first available peer comparator.

Closest listed HAE-focused comparator and relevant commercial/development peer; recent packet headlines indicate a PHVS trial win, increasing competitive monitoring risk, but primary confirmation and detailed comparative economics are unavailable.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerPHVSPharvaris
BCRX
BioCryst
PHVS
Pharvaris
Grade
A
D
Momentum
42
60
Value
71
41
Sentiment
100
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs PHVS

BCRX / PHVS
Grade Position
Above peers
BCRX vs. peer average (A vs. B)
74/100
Momentum
42
PHVS
Value
71
BCRX
Sentiment
100
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BCRX
1
PHVS
PHVS
D
40/100
+3
2
COAG
COAG
D
40/100
+3
3
KOD
Kodiak Sciences Inc Common
A
100/100
Even
4
RARE
Ultragenyx Pharmaceutical Inc Common
B
80/100
+1
5
NKTR
Nektar Therapeutics Common
B
80/100
+1
PHVS is the first peer returned for this comparison set.